ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19

Journal: Molecular Biology Research Communications (Vol.10, No. 3)

Publication Date:

Authors : ; ; ; ; ; ;

Page : 141-147

Keywords : microRNA; COVID-19; SARs-CoV-2; Biomarkers;

Source : Download Find it from : Google Scholarexternal

Abstract

COVID-19 represents a public health emergency, whose mechanism of which is not fully understood. It is speculated that microRNAs may play a crucial role in host cells after infection by SARS-CoV-2. Thus, our study aimed to analyze the expression of miR-200c-3p in saliva samples from patients with COVID-19. One handred eleven samples from patients with COVID-19 were divided into 4 groups. Group I: 39 patients negative for Covid-19; Group II: 37 positive and symptomatic patients, with no indication of hospitalization; Group III: 21 patients with respiratory disorders (hospitalized); Group IV: 14 patients with severe conditions (oxygen therapy). The expression levels of miR-200c-3p were determined using qPCR. We found greater expression of miR-200c-3p in patients in group IV (p <0.0001), and also verified that patients aged ≥42 years had a higher expression of this miR (p =0.013). Logistic regression analysis revealed that the expression of miR-200c-3p and systemic arterial hypertension are factors independently associated with patients in group IV (p <0.0001). Our results suggest that miR-200c-3p is a predictor of severity independent of COVID-19 risk factors, which could represent a way of screening patients affected by SARS-CoV-2.

Last modified: 2022-07-06 14:41:57